Skip to main content
. 2015 Nov 25;34(2):202–211. doi: 10.1016/j.vaccine.2015.11.043

Table 1.

Poultry DNA vaccination against viruses.

Pathogen Host Antigen Route Major immunological outcomes References
Avian Influenza Virus Chicken HA (mainly) or H5 or H7 or M IM
Or IV + SC + IP
Or ID/SC
Or IM
Or oral
Stimulation of CD4+ and CD8+ T-cells, Th1 cytokines. Hemagglutinin inhibition. High levels of protection (up to 16 out of 17 chickens protected from a severe challenge). [6], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28]
Duck HA ID/IM Induction of virus neutralizating antibodies and haemagglutination inhibition. [10]



Infectious Bursal Disease Virus Chicken VP2 or VP243 IM
Or IM + ID
Or IM + IP
Or oral
Or In ovo/IM
Or oral + eye
High level of protection against an experimental challenge, up to 100%. [5], [9], [29], [30], [31], [32], [33], [34], [35], [36]
Infectious Bronchitis Virus Chicken S1 and/or N and/or M or unique ORF with 7 epitopes IM
Or in ovo/IM
60–90% of protection against an experimental challenge. [7], [37], [38], [39], [40], [41]
Duck Hepatitis B Virus Duck preS/S and/or C IM Evaluation of new treatments based on DNA vaccination for humans. [42], [43], [44], [45], [46], [47]
Avian Reovirus Chicken σB and/or σC oral 66.7–75% protection against experimental challenges. [48], [92]
Chicken Anemia Virus Chicken VP1 and/or VP2 IM Induction of CD8+ T-cells, virus neutralization antibodies, IL-2 and IFN-γ. [3], [52], [93]
Newcastle Disease Virus Chicken F and/or H IN + IM
Or IN
Or IM
High level of protection, up to 100% protection against an experimental challenge. [13], [49], [72], [74], [77], [90]
Marek Disease Virus Chicken Herpesvirus genome IM/ID 55% of survivors after a severe experimental challenge. [50]
Infectious Laryngotracheitis Virus Chicken gB IM Decrease of mortality from 65–75% to 0%. [12]
Reticuloendotheliosis Virus Chicken Gp90 IM Induction of neutralizing antibodies. Proliferation and production of IL4 and IFN-γ by lymphocytes. Partial control of viremia after challenge (13/15 vs 2/15 in the control group). [51]
Turkey Rhinotracheitis Virus Turkey F and N IM Reduction in the level of virus shedding and induction of antibodies
Decrease of animals presenting clinical symptoms from 50–60% to 20–30%.
[53]
Turkey Coronavirus Turkey 4F/4R fragment of TCoVS IM Humoral immune response and decrease of turkeys showing clinical signs from 5/5 to 1/5 or 2/5. [54]
Duck Enteritis Virus Duck gB, gC, gD or UL24 IG
Or IM
Or IN
IgG, IgA and neutralizing antibodies. Up to 80% of survivors after challenge. [1], [86], [94]
Duck Plague Virus Duck gC IM
Or ID
Induction of virus specific serum IgG and neutralizing antibodies as well as lymphoproliferation. [55]